163 related articles for article (PubMed ID: 7616117)
1. Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome.
Batta AK; Tint GS; Shefer S; Abuelo D; Salen G
J Lipid Res; 1995 Apr; 36(4):705-13. PubMed ID: 7616117
[TBL] [Abstract][Full Text] [Related]
2. Cholesta-5,7,9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide.
De Fabiani E; Caruso D; Cavaleri M; Galli Kienle M; Galli G
J Lipid Res; 1996 Nov; 37(11):2280-7. PubMed ID: 8978479
[TBL] [Abstract][Full Text] [Related]
3. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid.
Rossiter JP; Hofman KJ; Kelley RI
Am J Med Genet; 1995 Apr; 56(3):272-5. PubMed ID: 7778588
[TBL] [Abstract][Full Text] [Related]
4. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome.
Tint GS; Irons M; Elias ER; Batta AK; Frieden R; Chen TS; Salen G
N Engl J Med; 1994 Jan; 330(2):107-13. PubMed ID: 8259166
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts.
Kelley RI
Clin Chim Acta; 1995 Apr; 236(1):45-58. PubMed ID: 7664465
[TBL] [Abstract][Full Text] [Related]
6. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome.
Batta AK; Salen G; Tint GS; Shefer S
J Lipid Res; 1995 Nov; 36(11):2413-8. PubMed ID: 8656079
[TBL] [Abstract][Full Text] [Related]
7. Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata.
Rakheja D; Boriack RL
Pediatr Dev Pathol; 2008; 11(2):128-32. PubMed ID: 17378665
[TBL] [Abstract][Full Text] [Related]
8. Smith-Lemli-Opitz syndrome: biochemical before clinical diagnosis; early dietary management.
Nwokoro NA; Hyde B; Mulvihill JJ
Am J Med Genet; 1994 May; 50(4):375-6. PubMed ID: 8209919
[TBL] [Abstract][Full Text] [Related]
9. A reliable tool for detecting 7-dehydrocholesterol and cholesterol in human plasma and its use in diagnosis of Smith-Lemli-Opitz syndrome.
Luo Y; Liu Z; Zeng Y; Zhang Y; Luan Y; Ma L; Chen L; Zou L; Yang J; Huang Z; Rao Y; Zhang C
J Sep Sci; 2022 Mar; 45(5):1080-1093. PubMed ID: 34962712
[TBL] [Abstract][Full Text] [Related]
10. Abnormal bile acids in the Smith-Lemli-Opitz syndrome.
Natowicz MR; Evans JE
Am J Med Genet; 1994 May; 50(4):364-7. PubMed ID: 8209917
[TBL] [Abstract][Full Text] [Related]
11. Sterols in blood of normal and Smith-Lemli-Opitz subjects.
Ruan B; Wilson WK; Pang J; Gerst N; Pinkerton FD; Tsai J; Kelley RI; Whitby FG; Milewicz DM; Garbern J; Schroepfer GJ
J Lipid Res; 2001 May; 42(5):799-812. PubMed ID: 11352988
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
[TBL] [Abstract][Full Text] [Related]
13. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS
J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
[TBL] [Abstract][Full Text] [Related]
14. Desmosterolosis and desmosterol homeostasis in the developing mouse brain.
Allen LB; Genaro-Mattos TC; Porter NA; Mirnics K; Korade Z
J Inherit Metab Dis; 2019 Sep; 42(5):934-943. PubMed ID: 30891795
[TBL] [Abstract][Full Text] [Related]
15. Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry.
Seedorf U; Fobker M; Voss R; Meyer K; Kannenberg F; Meschede D; Ullrich K; Horst J; Benninghoven A; Assmann G
Clin Chem; 1995 Apr; 41(4):548-52. PubMed ID: 7720244
[TBL] [Abstract][Full Text] [Related]
16. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient.
Irons M; Elias ER; Tint GS; Salen G; Frieden R; Buie TM; Ampola M
Am J Med Genet; 1994 May; 50(4):347-52. PubMed ID: 8209913
[TBL] [Abstract][Full Text] [Related]
17. Aberrant pathways in the late stages of cholesterol biosynthesis in the rat. Origin and metabolic fate of unsaturated sterols relevant to the Smith-Lemli-Opitz syndrome.
Ruan B; Tsai J; Wilson WK; Schroepfer GJ
J Lipid Res; 2000 Nov; 41(11):1772-82. PubMed ID: 11060346
[TBL] [Abstract][Full Text] [Related]
18. [Biochemical diagnosis of Smith-Lemli-Opitz syndrome in a patient with congenital adrenal hyperplasia].
GarcíaFuentes E; icioso Recio MV ; del Castillo Acedo Del Olmo E ; atas Jurado MM ; Arana Agüera M ; López López J
An Esp Pediatr; 2000 Nov; 53(5):482-7. PubMed ID: 11141372
[TBL] [Abstract][Full Text] [Related]
19. [Historical aspects of the Smith-Lemli-Opitz syndrome].
Bzdúch V; Behúlová D; Skodová J; Skokňová M; Kozák L
Cas Lek Cesk; 2014; 153(1):36-9. PubMed ID: 24506692
[TBL] [Abstract][Full Text] [Related]
20. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
